The evidence is clear: vaccines are one of the most cost-effective investments in health and development in history. Gavi helps save children’s lives and protect people’s health by increasing access to immunisation in poor countries.
7 million deaths averted
Since its launch in 2000, Gavi has helped developing countries to prevent more than 7 million future deaths from hepatitis B, Haemophilus influenzae type b (Hib), measles, meningitis A, pneumococcal disease, rotavirus diarrhoea and yellow fever.
Source: Gavi/Bill & Melinda Gates Foundation
500 million children immunised
Since 2000, Gavi support has contributed to the immunisation of an additional 500 million children.
Reaching 76% coverage with DTP3
DTP3 coverage reached 76% in 2013 in the 73 countries supported by the Alliance.
Almost 4 million deaths averted between 2011 and 2015
The Alliance’s support for vaccines will contribute to averting an estimated 3.9 million future deaths between 2011 and 2015.
Nearly a quarter of a billion immunised by 2015
Gavi support will assist countries to immunise a further 243 million children between 2011 and 2015.
11 million children vaccinated against pneumococcal disease
Gavi support had contributed to immunising 11 million children against pneumococcal disease by the end of 2013.
Over 4 million children vaccinated against rotavirus
Gavi support had contributed to immunising more than four million children against rotavirus diarrhoea by the end of 2013.
More than 150 million people immunised against meningitis A
By the end of 2013, 11 countries in the African meningitis belt had collectively immunised 153 million people against meningitis A with support from the Vaccine Alliance.